The article explores how modern technology is revolutionizing diabetes care by integrating conti­nuous glucose monitoring (CGM), predictive analytics, and remote healthcare solutions. With over 500 million people globally affected by diabetes, and rising prevalence in countries like Ukraine, effective and adaptive management is critical. The goal of this paper is to present how modern technologies, specifically the GluComp platform, enhance diabetes management by integrating continuous glucose monitoring and personalized machine learning models. It aims to demonstrate how real-time data, predictive analytics, and modular design enable proactive and adaptive care for patients with diabetes. Traditional diabetes monitoring methods, such as fingerstick blood tests, are limited in providing real-time data. Newer CGM technologies like Dexcom and Freestyle Libre enable continuous, non-invasive monitoring of glucose levels, producing time series data essential for detecting patterns and predicting dangerous fluctuations (hypo- or hyperglycemia). The use of deep learning and neural network algorithms enhances the accuracy of these predictions by capturing complex data trends over time. A key innovation discussed is GluComp, a modular digital health platform designed to improve diabetes management. GluComp integrates CGM systems with personalized machine learning models to deliver real-time alerts, predictive insights, and adaptive care. It supports offline functionality for rural or under-resourced areas, and offers intuitive dashboards for patients and healthcare providers, boosting engagement and treatment adherence. The article also addresses the challenges in Ukraine’s healthcare system, especially for diabetes patients in economically disadvantaged or rural areas, where access to CGMs and insulin pumps is limited due to high costs. Despite these challenges, progress is being made through public health initiatives, mobile health apps, and government support programs aimed at increasing awareness and access to care. Special attention is given to the military population, for whom CGM technology could be critical due to high physical and psychological stress levels, irregular routines, and limited access to immediate medical care. Implementing CGM in military settings could enhance operational readiness and transfer innovations to civilian healthcare. Smart diabetes management using platforms like GluComp — through real-time monito­ring, predictive modeling, and personalized care — is a transformative step in chronic disease management. It holds promise for improving outcomes, reducing complications, and enhancing quality of life, especially when adapted to meet the needs of underserved populations.